Pharma Journalist - Page 769 of 923 -

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

Introducing the 2nd Annual HPAPI Conference this May 2018

Discover Novel Based Vial Based Technology, Presented by Roche this May

FDA authorization extended to 23andMe for Direct-to Consumer Genetic Test on Cancer Risk

Theratechnologies states FDA approval of innovative therapy, Trogarzo Injection

FDA sanctions Trogarzo as HIV treatment for untreated patients

FDA sanctions AFIA for detecting antibodies to Babesia microti and Imugen Babesia microti NAT

Contego Medical commences enrollment in the PERFORMANCE I Trial

Magenta Therapeutics and Heidelberg Pharma sign agreement on Development of Antibody Drug Conjugates

City of Hope scientists and doctors proclaim New drug to combat Chronic myelogenous leukemia